Cheryl L Brunelle1, Meyha N Swaroop2, Melissa N Skolny3, Maria S Asdourian3, Hoda E Sayegh3, Alphonse G Taghian4. 1. Department of Physical and Occupational Therapy, Massachusetts General Hospital, Boston, Massachusetts. 2. Department of Radiation Oncology, Massachusetts General Hospital, and Harvard Medical School, Boston, Massachusetts. 3. Department of Radiation Oncology, Massachusetts General Hospital, and Harvard Medical School. 4. Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114 (USA).
Abstract
Background: There is little research on hand edema in the population at risk for breast cancer-related lymphedema (BCRL). Objectives: Study aims included reporting potential importance of hand edema (HE) as a risk factor for progression of edema in patients treated for breast cancer at risk for BCRL, reporting risk factors for BCRL, and reporting treatment of HE. Design/ Methods: This was a retrospective analysis of 9 patients treated for breast cancer in Massachusetts General Hospital's lymphedema screening program who presented with isolated HE. Limb volumes via perometry, BCRL risk factors, and HE treatment are reported. Results: Edema was mostly isolated to the hand. Three patients had arm edema >5% on perometry; and 2 of these had edema outside the hand on clinical examination. Patients were at high risk of BCRL with an average of 2.9/5 known risk factors. Arm edema progressed to >10% in 2 high-risk patients. Treatment resulted in an average hand volume reduction of 10.2% via perometry and improvement upon clinical examination. Limitations: The small sample size and lack of validated measures of subjective data were limitations. Conclusions: In this cohort, patients with HE carried significant risk factors for BCRL. Two out of 9 (22%), both carrying ≥4/5 risk factors, progressed to edema >10%. Isolated HE may be a prognostic factor for edema progression in patients treated for breast cancer at risk for BCRL. Further research is warranted.
Background: There is little research on hand edema in the population at risk for breast cancer-related lymphedema (BCRL). Objectives: Study aims included reporting potential importance of hand edema (HE) as a risk factor for progression of edema in patients treated for breast cancer at risk for BCRL, reporting risk factors for BCRL, and reporting treatment of HE. Design/ Methods: This was a retrospective analysis of 9 patients treated for breast cancer in Massachusetts General Hospital's lymphedema screening program who presented with isolated HE. Limb volumes via perometry, BCRL risk factors, and HE treatment are reported. Results:Edema was mostly isolated to the hand. Three patients had arm edema >5% on perometry; and 2 of these had edema outside the hand on clinical examination. Patients were at high risk of BCRL with an average of 2.9/5 known risk factors. Arm edema progressed to >10% in 2 high-risk patients. Treatment resulted in an average hand volume reduction of 10.2% via perometry and improvement upon clinical examination. Limitations: The small sample size and lack of validated measures of subjective data were limitations. Conclusions: In this cohort, patients with HE carried significant risk factors for BCRL. Two out of 9 (22%), both carrying ≥4/5 risk factors, progressed to edema >10%. Isolated HE may be a prognostic factor for edema progression in patients treated for breast cancer at risk for BCRL. Further research is warranted.
Authors: Anthony W B Stanton; Stephanie Modi; Russell H Mellor; A Mike Peters; William E Svensson; J Rodney Levick; Peter S Mortimer Journal: Clin Sci (Lond) Date: 2006-05 Impact factor: 6.124
Authors: Nicole L Stout; Lucinda A Pfalzer; Barbara Springer; Ellen Levy; Charles L McGarvey; Jerome V Danoff; Lynn H Gerber; Peter W Soballe Journal: Phys Ther Date: 2011-09-15
Authors: Nicole L Stout; Lucinda A Pfalzer; Ellen Levy; Charles McGarvey; Barbara Springer; Lynn H Gerber; Peter Soballe Journal: PM R Date: 2011-10-05 Impact factor: 2.298
Authors: Marek Ancukiewicz; Tara A Russell; Jean Otoole; Michelle Specht; Marybeth Singer; Alexandra Kelada; Colleen D Murphy; Jessica Pogachar; Valeria Gioioso; Megha Patel; Melissa Skolny; Barbara L Smith; Alphonse G Taghian Journal: Int J Radiat Oncol Biol Phys Date: 2010-06-03 Impact factor: 7.038
Authors: Nicole L Stout; Jill M Binkley; Kathryn H Schmitz; Kimberly Andrews; Sandra C Hayes; Kristin L Campbell; Margaret L McNeely; Peter W Soballe; Ann M Berger; Andrea L Cheville; Carol Fabian; Lynn H Gerber; Susan R Harris; Karin Johansson; Andrea L Pusic; Robert G Prosnitz; Robert A Smith Journal: Cancer Date: 2012-04-15 Impact factor: 6.860
Authors: F M Boccardo; F Ansaldi; C Bellini; S Accogli; G Taddei; G Murdaca; C C Campisi; G Villa; G Icardi; P Durando; F Puppo; C Campisi Journal: Lymphology Date: 2009-03 Impact factor: 1.286
Authors: Fangdi Sun; Alexander Hall; Megan P Tighe; Cheryl L Brunelle; Hoda E Sayegh; Tessa C Gillespie; Kayla M Daniell; Alphonse G Taghian Journal: Breast Cancer Res Treat Date: 2018-07-30 Impact factor: 4.872
Authors: Ann Marie Flores; Jason Nelson; Lee Sowles; Rebecca G Stephenson; Kathryn Robinson; Andrea Cheville; Antoinette P Sander; William J Blot Journal: Phys Ther Date: 2020-03-10